ClearPoint Neuro's EBIT per Share for the
three
months ended in Dec. 2023 was $-0.19.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.91.
During the past 3 years, the average EBIT per Share Growth Rate was -32.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -17.60% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 22.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for ClearPoint Neuro's EBIT per Share or its related term are showing as below:
CLPT'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -32.5 Med: 21.8 Max: 51.1
Current: -32.5
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of ClearPoint Neuro was 51.10% per year. The lowest was -32.50% per year. And the median was 21.80% per year.
CLPT's 3-Year EBIT Growth Rate is ranked worse than 86.4% of 728
companies
in the Medical Devices & Instruments industry
Industry Median: 6.2
vs CLPT: -32.50
The historical data trend for ClearPoint Neuro's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.91
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ClearPoint Neuro (NAS:CLPT) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
ClearPoint Neuro EBIT per Share Related Terms
Thank you for viewing the detailed overview of ClearPoint Neuro's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
ClearPoint Neuro (ClearPoint Neuro) Business Description
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace is used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint neuro system, MRI-guided drug delivery, and Thermal therapy system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLPT has been successfully added to your 